BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 28285366)

  • 1. Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review.
    Barton V; Armeson K; Hampras S; Ferris LK; Visvanathan K; Rollison D; Alberg AJ
    Arch Dermatol Res; 2017 May; 309(4):243-251. PubMed ID: 28285366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis.
    Marcil I; Stern RS
    Arch Dermatol; 2000 Dec; 136(12):1524-30. PubMed ID: 11115165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
    Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
    JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of a history of skin cancer in 2007: results of an incidence-based model.
    Stern RS
    Arch Dermatol; 2010 Mar; 146(3):279-82. PubMed ID: 20231498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group.
    Karagas MR; McDonald JA; Greenberg ER; Stukel TA; Weiss JE; Baron JA; Stevens MM
    J Natl Cancer Inst; 1996 Dec; 88(24):1848-53. PubMed ID: 8961975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load.
    Asgari MM; Ray GT; Quesenberry CP; Katz KA; Silverberg MJ
    JAMA Dermatol; 2017 Sep; 153(9):892-896. PubMed ID: 28700773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and clinical evolution of non-melanoma skin cancer in renal transplant recipients: a single-center experience in São Paulo, Brazil.
    Hayashida MZ; Fernandes VM; Fernandes DR; Ogawa MM; Tomimori J
    Int J Dermatol; 2015 Oct; 54(10):e383-8. PubMed ID: 25969871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and prevalence of non-melanoma skin cancer in Australia: A systematic review.
    Perera E; Gnaneswaran N; Staines C; Win AK; Sinclair R
    Australas J Dermatol; 2015 Nov; 56(4):258-67. PubMed ID: 25716064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
    Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study.
    Lewis KG; Weinstock MA
    Arch Dermatol; 2004 Jul; 140(7):837-42. PubMed ID: 15262694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of nonmelanoma skin cancer in New Brunswick, Canada, 1992 to 2001.
    Hayes RC; Leonfellner S; Pilgrim W; Liu J; Keeling DN
    J Cutan Med Surg; 2007; 11(2):45-52. PubMed ID: 17374314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonmelanoma skin carcinoma in Albuquerque, New Mexico: experience of a major health care provider.
    Hoy WE
    Cancer; 1996 Jun; 77(12):2489-95. PubMed ID: 8640697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.
    van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E
    J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personal history of psoriasis and risk of nonmelanoma skin cancer (NMSC) among women in the United States: A population-based cohort study.
    Dai H; Li WQ; Qureshi AA; Han J
    J Am Acad Dermatol; 2016 Oct; 75(4):731-735. PubMed ID: 27436157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratinocyte Carcinoma as a Marker of a High Cancer-Risk Phenotype.
    Small J; Barton V; Peterson B; Alberg AJ
    Adv Cancer Res; 2016; 130():257-91. PubMed ID: 27037755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of nonmelanoma skin cancer.
    Strom SS; Yamamura Y
    Clin Plast Surg; 1997 Oct; 24(4):627-36. PubMed ID: 9342506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing demographics and pathology of nonmelanoma skin cancer in the last 30 years.
    Collins GL; Nickoonahand N; Morgan MB
    Semin Cutan Med Surg; 2004 Mar; 23(1):80-3. PubMed ID: 15095919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of second primary cancer and death following a diagnosis of nonmelanoma skin cancer.
    Nugent Z; Demers AA; Wiseman MC; Mihalcioiu C; Kliewer EV
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2584-90. PubMed ID: 16284382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival after squamous cell and basal cell carcinoma of the skin: A retrospective cohort analysis.
    Rees JR; Zens MS; Celaya MO; Riddle BL; Karagas MR; Peacock JL
    Int J Cancer; 2015 Aug; 137(4):878-884. PubMed ID: 25598534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonmelanoma skin cancer in an Irish population: an appraisal of risk factors.
    Healy E; Collins P; Barnes L
    Ir Med J; 1995; 88(2):58-9. PubMed ID: 7775148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.